Combination GnRH antagonists for endometriosis: Balancing efficacy with side effects

Other OA: gold CC0 ⤵ 5 in-corpus citations
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-12 ⓘ

This paper reviews trials of Relugolix, a combined hormone replacement therapy and GnRH antagonist, for treating endometriosis-associated pain.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is a chronic pain condition affecting 1 in 10 women. There is an unmet need for better medical treatments for endometriosis. We spotlight trials of a single preparation combined HRT-GnRH antagonist (Relugolix) by Giudice et al.,1 for endometriosis-associated pain.

My notes (saved in your browser only)

Outcome instruments

EHP-30 NRS-pain COS-Endo-2020

Condition tags

endometriosisdysmenorrheadyspareuniainfertility

MeSH descriptors

Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (10)

Cited by (5)

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:36:45.364535+00:00
License: CC0 · commercial use OK